Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronocort vs Plenadren in adrenal insufficiency (Phase II crossover study)
2021-000144-21Phase 2Completed
- Sponsor
- Diurnal Group plc
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of hydrocortisone modified-release and hydrocortisone in hypoadrenocorticism and Addison's disease (2 arms), sponsored by Diurnal Group plc. Started Aug 2021; status: completed.
02
Drugs
hydrocortisone modified-releasehydrocortisone
03
Conditions
hypoadrenocorticismAddison's disease
Beyond the preview
Go deeper on 2021-000144-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000144-21.